Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance

por Murai, Hiroyuki, Suzuki, Shigeaki, Hasebe, Miki, Fukamizu, Yuji, Rodrigues, Ema, Utsugisawa, Kimiaki
Publicado 2021

Comorbidities in patients with migraine in Japan: a cross-sectional study using data from National Health and Wellness Survey

por Kikui, Shoji, Chen, Yirong, Ikeda, Ken, Hasebe, Miki, Asao, Keiko, Takeshima, Takao
Publicado 2022

Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis

por Kitamura, Shigekazu, Takeshima, Takao, Yui, Daishi, da Silva Lima, Gabriel Paiva, Koukakis, Reija, Peng, Cheng, Yoshida, Ryuji, Numachi, Yotaro, Hasebe, Miki
Publicado 2023

Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trial

por Hirata, Koichi, Takeshima, Takao, Sakai, Fumihiko, Numachi, Yotaro, Yoshida, Ryuji, Koukakis, Reija, Hasebe, Miki, Yui, Daishi, da Silva Lima, Gabriel Paiva, Cheng, Sunfa
Publicado 2023